Trial Profile
An Open-label Study to Compare the Pharmacokinetic Profiles of a Single Dose of Ferriprox in Subjects With Impaired Renal Function and Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Deferiprone (Primary)
- Indications Friedreich's ataxia
- Focus Pharmacokinetics
- Sponsors ApoPharma
- 01 Aug 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 29 Jan 2013 New trial record
- 01 Jan 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.